Ad
related to: federal substance abuse confidentiality laws
Search results
Results From The WOW.Com Content Network
The Comprehensive Drug Abuse Prevention and Control Act of 1970, Pub. L. 91–513, 84 Stat. 1236, enacted October 27, 1970, is a United States federal law that, with subsequent modifications, requires the pharmaceutical industry to maintain physical security and strict record keeping for certain types of drugs. [1]
The Anti-Drug Abuse Acts of 1986 and 1988 increased penalties and established mandatory sentencing for drug violations. The Office of National Drug Control Policy was created in 1989. Although these additional laws increased drug-related arrest throughout the country, they also incarcerated more African Americans than whites.
President Ronald Reagan signed the law due to the amount of drug abuse occurring in the military. Drug abuse had become such a huge problem that "He issued Executive Order 12564 banning all federal employees (on and off duty) from using drugs." [3] Soon after this law went into effect, smaller corporations adopted the same rules. [3]
21 U.S.C. ch. 13 — Drug Abuse Prevention and Control Controlled Substances Act, a part of the Comprehensive Drug Abuse Prevention and Control Act of 1970. 21 U.S.C. ch. 14 — [Alcohol and Drug Abuse Educational Programs and Activities] (repealed) 21 U.S.C. ch. 15 — Egg Products Inspection
The ADAA projected budget for the total federal drug control budget (if fully funded) was $6.5 billion for the 1989 fiscal year”. [6] The result of the Anti-Drug Abuse Act of 1988 was not foreseen. “After spending billions of dollars on law enforcement, doubling the number of arrests and incarcerations, and building prisons at a record pace ...
(c) The patient has the right to be free from all forms of abuse or harassment. (5) Confidentiality of Patient Records. (a) The patient has the right to the confidentiality of his or her clinical records. (b) The patient has the right to access information contained in his or her clinical records within a reasonable time frame.
SUPPORT for Patients and Communities Act, also known as Substance Use–Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, (H.R. 6, Pub. L. 115–271 (text)) is a United States federal law, enacted during the 115th United States Congress, to make medical treatment for opioid addiction more widely available while also cracking down on illicit drugs.
An Act to amend the Comprehensive Drug Abuse Prevention and Control Act of 1970 and other laws to meet obligations under the Convention on Psychotropic Substances relating to regulatory controls on the manufacture, distribution, importation, and exportation of psychotropic substances, and for other purposes. Acronyms (colloquial) PSA: Nicknames